← Back to Search

Yoga for Multiple Myeloma

N/A

Recruiting

Led By Shaunak Pandya, MD

Research Sponsored by University of Arizona

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of multiple myeloma on active treatment as determined by investigators

Good performance status as defined by European Cooperative Oncology Group score 0-1

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-weeks

Awards & highlights

Study Summary

This trial aims to see if weekly yoga can help Multiple Myeloma patients manage physical, psychological, and overall health symptoms.

Who is the study for?

This trial is for adults over 18 with multiple myeloma who are currently receiving treatment. Participants should be able to use a computer or smartphone, attend weekly yoga sessions at a studio, and understand English. They must be in good physical condition as judged by specific medical criteria and not involved in another clinical study.Check my eligibility

What is being tested?

The study tests how feasible it is to have weekly yoga sessions for multiple myeloma patients undergoing treatment. It looks at the effects of yoga on physical discomforts like pain and fatigue, mental health issues such as anxiety, and overall life quality.See study design

What are the potential side effects?

Since this trial involves yoga interventions rather than medication, side effects may include muscle soreness or strain from the physical activity. However, serious side effects are unlikely given the nature of yoga.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently receiving treatment for multiple myeloma.

Select...

I am fully active or able to carry out light work.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Accrual rate of yoga intervention study

Compliance rate of weekly yoga intervention

Secondary outcome measures

Short-term impact of yoga intervention on health-related quality of life (HRQOL)

Short-term impact of yoga intervention on resting heart rate

Short-term impact of yoga intervention on symptom burden

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Immediate yoga groupExperimental Treatment1 Intervention

20 participants randomized to immediate yoga intervention group will participate together in a weekly 40-minute guided mindful yoga intervention for a total of 12 consecutive weeks. After each session, participants will be asked to complete the Edmonton Symptom Assessment System (ESAS-r) through MyDataHelps app. At the end of each session, participants will be asked additional questions via MyDataHelps such as completion of yoga session on-site or remotely, the length of time they participated in the session, any additional yoga sessions during the past week, and comments regarding the session/intervention. These participants will also complete health-related quality of life (HRQOL) assessment (EORTC QLQ-C30) at baseline, 6 weeks, and 12 weeks during active yoga intervention.

Group II: Waitlist yoga group (delayed yoga intervention group)Active Control1 Intervention

20 participants randomized to this group will start the yoga intervention at week 13 and participate in 12 consecutive weeks of weekly 40 minute guided mindful yoga. Participants in this group will complete ESAS-r every 3 weeks and EORTC QLQ-C30 every 6 weeks for the first 12 weeks. These participants will also complete HRQOL assessment (EORTC QLQ-C30) at baseline, 6 weeks, and 12 weeks during active yoga intervention, weeks 13-24.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor

515 Previous Clinical Trials

148,674 Total Patients Enrolled

7 Trials studying Multiple Myeloma

811 Patients Enrolled for Multiple Myeloma

Shaunak Pandya, MDPrincipal InvestigatorUniversity of Arizona

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible to join this research endeavor at present?

"Per the clinicaltrials.gov website, this medical study is not currently recruiting patients. The trial began on October 1st 2023 and was last updated 27th September of the same year; nevertheless, 813 other studies are actively looking for participants at this moment in time."

Answered by AI

What are the main objectives that this clinical study seeks to accomplish?

"The primary goal of this clinical study, which is conducted over the span of 12 weeks, is to assess accrual rate in relation to a yoga intervention. Secondary objectives include evaluating the immediate impact of said program on health-related quality of life (HRQOL) through administering an EORTC QLQ-C30 questionnaire; total daily activity using wearable device (FitBit); and resting heart rate also measured by FitBit. It is hypothesized that patients with multiple myeloma will experience improved HRQOL scores at 6 and 12 week checkpoints compared to baseline and controls due to weekly mindful yoga sessions as well as increased steps taken"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Multiple Myeloma Yoga Pilot Study

2023. "Multiple Myeloma Yoga Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06061302.

All > Tucson